Breaking News Instant updates and real-time market news.

GRPN

Groupon

$4.43

0.08 (1.84%)

12:40
04/13/18
04/13
12:40
04/13/18
12:40

Bullish short-term play opened in Groupon

Bullish short-term play opened in Groupon. Shares flat at $4.43 and 10K May 4 puts trade at 18c along with 10K May 4.5 - 5 call spreads for 20c. The investor sold puts to buy the call spread, paying 2c, for five-weeks of upside exposure and into earnings 5/2. The position expresses confidence that shares won't fall 9.7% to less than $4 through the May expiration and offers a max payout of 48c if the stock rallies 12.9% to $5 or better. The stock down 10.9% since a 9.7% earnings gap move lower to $4.71 on 2/14/18 after the last profit report. 52-week high of $5.86 set in December and the low of $3.01 was recorded in May.

GRPN Groupon
$4.43

0.08 (1.84%)

03/05/18
03/05/18
UPGRADE
Target $4.4

Equal Weight
Morgan Stanley sees Groupon selloff as overdone, upgrades to Equal Weight
As previously reported, Morgan Stanley analyst Jonathan Lanterman upgraded Groupon to Equal Weight from Underweight, as he sees the stock being fairly valued with limited downside following the 20% selloff since its report of Q4 earnings. Lanterman has increased his 2018 adjusted EBITDA estimates by 2% and is now at the high end of the company's adjusted EBITDA guidance range, largely due to what he feels is more realistic SG&A modeling, he tells investors. He raised his price target on Groupon shares to $4.40 from $4.30.
03/05/18
MSCO
03/05/18
UPGRADE
MSCO
Equal Weight
Groupon upgraded to Equal Weight from Underweight at Morgan Stanley
02/14/18
PIPR
02/14/18
NO CHANGE
Target $6.25
PIPR
Overweight
Piper Jaffray would be a buyer of Groupon on post-earnings pullback
Piper Jaffray analyst Sam Kemp said Groupon reported strong Q4 gross profit and EBITDA and he believes the lower than expected North America Local billing growth of 2.5% is largely explained by an accounting headwind created by the shift to Groupon+. His first take on the company's 2018 EBITDA guidance is that it implies a significant ramp in international marketing and "heavy levels of conservatism," said Kemp, who thinks the implied gross profit view is in line with consensus expectations. He would be a buyer of the stock on the pullback and maintains his Overweight rating and $6.25 price target on Groupon shares, which are down nearly 9% to $4.75 in early trading.
01/17/18
01/17/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. IBM (IBM) upgraded to Overweight from Underweight at Barclays with analyst Mark Moskowitz saying the company could be entering a period of top-line stability and maybe even modest growth over the next 12-18 months. 2. Ulta Beauty (ULTA) upgraded to Overweight from Equal Weight at Morgan Stanley with analyst Simeon Gutman saying Ulta shares are trading at a compelling multiple given the company's long runway for earnings per share growth combined with benefits from lower tax rates. 3. Groupon (GRPN) upgraded to Neutral from Sell at Goldman Sachs with analyst Christopher Merwin saying stabilizing gross profit growth, coupled with cost savings, should drive upside to Street EBITDA expectations in 2018. 4. L3 Technologies (LLL) upgraded to Buy from Neutral at BofA/Merrill with analyst Ronald Epstein saying it will benefit from "upward momentum" in the U.S. defense budget. 5. Dick's Sporting (DKS) upgraded to Buy from Neutral at Buckingham with the firm citing tax reform benefits and recent strength across retail. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

TODAY'S FREE FLY STORIES

HQCL

Hanwah Q Cells

$8.20

-0.13 (-1.56%)

17:07
10/15/18
10/15
17:07
10/15/18
17:07
Hot Stocks
Hanwah Q Cells up 8.5% after agreeing to be acquired by Hanwha Solar »

In after-hours trading,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MBRX

Moleculin Biotech

$1.38

-0.005 (-0.36%)

17:06
10/15/18
10/15
17:06
10/15/18
17:06
Syndicate
Breaking Syndicate news story on Moleculin Biotech »

Moleculin Biotech files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CRY

CryoLife

$30.64

0.42 (1.39%)

17:04
10/15/18
10/15
17:04
10/15/18
17:04
Earnings
CryoLife reports preliminary Q3 revenue $64.6M, consensus $61.84M »

Preliminary and unaudited…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TRQ

Turquoise Hill

$1.96

-0.015 (-0.76%)

, RIO

Rio Tinto

$49.54

0.34 (0.69%)

17:03
10/15/18
10/15
17:03
10/15/18
17:03
Hot Stocks
Turquoise Hill provides underground development update »

Turquoise Hill (TRQ)…

TRQ

Turquoise Hill

$1.96

-0.015 (-0.76%)

RIO

Rio Tinto

$49.54

0.34 (0.69%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PANW

Palo Alto Networks

$209.49

-2.51 (-1.18%)

17:02
10/15/18
10/15
17:02
10/15/18
17:02
Earnings
Palo Alto Networks backs Q1 EPS view $1.04-$1.06, consensus $1.06 »

Backs Q1 revenue view of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

  • 10

    Dec

TRQ

Turquoise Hill

$1.96

-0.015 (-0.76%)

17:01
10/15/18
10/15
17:01
10/15/18
17:01
Hot Stocks
Turquoise Hil reports Q3 throughput down 5% y/y »

Turquoise Hill Resources…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HQCL

Hanwah Q Cells

$8.20

-0.13 (-1.56%)

17:01
10/15/18
10/15
17:01
10/15/18
17:01
Hot Stocks
Breaking Hot Stocks news story on Hanwah Q Cells »

Hanwha Q CELLS trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PANW

Palo Alto Networks

$209.49

-2.51 (-1.18%)

17:00
10/15/18
10/15
17:00
10/15/18
17:00
Hot Stocks
Palo Alto Networks names Amit Singh as President »

Palo Alto Networks…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

  • 10

    Dec

BCOR

Blucora

$32.96

-0.23 (-0.69%)

16:59
10/15/18
10/15
16:59
10/15/18
16:59
Hot Stocks
Blucora names Tran Taylor chief HR officer »

Blucora announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FB

Facebook

$153.56

-0.2 (-0.13%)

16:56
10/15/18
10/15
16:56
10/15/18
16:56
Periodicals
Facebook to ban false information on voting ahead of midterms, Reuters says »

Facebook plans to ban…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Oct

  • 30

    Oct

  • 07

    Nov

ADBE

Adobe

$238.05

-10.84 (-4.36%)

16:55
10/15/18
10/15
16:55
10/15/18
16:55
Conference/Events
Adobe to host financial analyst meeting »

Financial Analyst Meeting…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Oct

LDOS

Leidos

$66.00

0.91 (1.40%)

16:50
10/15/18
10/15
16:50
10/15/18
16:50
Hot Stocks
Leidos achieves CMMI Level 3 for Development »

Leidos announced that the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Oct

AGN

Allergan

$183.03

-0.275 (-0.15%)

, ACRS

Aclaris Therapeutics

$13.38

-0.21 (-1.55%)

16:50
10/15/18
10/15
16:50
10/15/18
16:50
Conference/Events
Aclaris Therapeutics to host conference call »

Conference call to…

AGN

Allergan

$183.03

-0.275 (-0.15%)

ACRS

Aclaris Therapeutics

$13.38

-0.21 (-1.55%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Oct

  • 30

    Oct

  • 27

    Nov

SEND

SendGrid

$30.94

0.04 (0.13%)

16:47
10/15/18
10/15
16:47
10/15/18
16:47
Hot Stocks
Breaking Hot Stocks news story on SendGrid »

SendGrid spikes up over…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TWLO

Twilio

$76.26

1.27 (1.69%)

, SEND

SendGrid

$30.94

0.04 (0.13%)

16:45
10/15/18
10/15
16:45
10/15/18
16:45
Hot Stocks
Twilio to acquire SendGrid for $2B or $36.92 per share in all-stock deal »

Twilio (TWLO) and…

TWLO

Twilio

$76.26

1.27 (1.69%)

SEND

SendGrid

$30.94

0.04 (0.13%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

HQCL

Hanwah Q Cells

$8.20

-0.13 (-1.56%)

16:45
10/15/18
10/15
16:45
10/15/18
16:45
Hot Stocks
Hanwah Q Cells to be acquired by Hanwha Solar for ~ $825M equity value »

Hanwha Q CELLS announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TGE

Tallgrass Energy

$23.73

0.17 (0.72%)

16:45
10/15/18
10/15
16:45
10/15/18
16:45
Hot Stocks
Tallgrass Energy increases quarterly dividend 2.5% »

Tallgrass Energy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WAGE

WageWorks

$41.55

0.42 (1.02%)

16:42
10/15/18
10/15
16:42
10/15/18
16:42
Hot Stocks
WageWorks appoints Ismail Dawood as CFO »

The board of WageWorks…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

COT

Cott Corp.

$14.80

-0.05 (-0.34%)

16:37
10/15/18
10/15
16:37
10/15/18
16:37
Hot Stocks
Cott Corp. subsidiary acquires Mountain Valley for $78.5M »

Cott Corp. announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Nov

EBS

Emergent BioSolutions

$60.47

-0.4 (-0.66%)

16:36
10/15/18
10/15
16:36
10/15/18
16:36
Hot Stocks
Emergent BioSolutions completes Adapt Pharma acquisition »

Emergent BioSolutions …

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Nov

EIGR

Eiger BioPharmaceuticals

$10.25

0.05 (0.49%)

16:35
10/15/18
10/15
16:35
10/15/18
16:35
Hot Stocks
Breaking Hot Stocks news story on Eiger BioPharmaceuticals »

683 Capital reports 5.9%…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

RPD

Rapid7

$33.33

-0.59 (-1.74%)

16:33
10/15/18
10/15
16:33
10/15/18
16:33
Hot Stocks
Rapid7 acquires tCell.io, terms not disclosed »

Rapid7, Inc. announced it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

  • 06

    Nov

  • 13

    Nov

KALU

Kaiser Aluminum

$102.46

1.04 (1.03%)

16:32
10/15/18
10/15
16:32
10/15/18
16:32
Hot Stocks
Kaiser Aluminum authorizes additional $100M for share repurchases »

The Board of Directors…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

ATRO

Astronics

$33.40

1.28 (3.99%)

16:32
10/15/18
10/15
16:32
10/15/18
16:32
Hot Stocks
Astronics announces FAA granted approval for its LED lights »

Astronics Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BXS

BancorpSouth

$30.54

0.37 (1.23%)

16:32
10/15/18
10/15
16:32
10/15/18
16:32
Hot Stocks
BancorpSouth launches tax credit investment department »

BancorpSouth Bank will…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.